生命科学市场的验证、校准和标准化

预计生命科学领域验证、校准和标准化的全球市场规模将从 2025 年的 28 亿美元成长到 2030 年的 39 亿美元，2025 年至 2030 年的复合年增长率为 6.7%。

预计北美市场将从 2025 年的 11 亿美元成长到 2030 年的 16 亿美元，2025 年至 2030 年的复合年增长率为 6.8%。

预计亚太市场将从 2025 年的 6.982 亿美元成长到 2030 年的 9.972 亿美元，2025 年至 2030 年的复合年增长率为 7.4%。

本报告考察了生命科学领域的验证、校准和标准化的全球市场，提供了市场概述、市场影响因素和机会分析、技术和专利趋势、法律制度、历史和预测的市场规模、按各个细分市场和地区进行的详细分析以及主要企业的概况。

目录

第一章执行摘要

• 市场展望
• 调查范围
• 市场概况
• 概述
• 当前市场状况
• 细分市场分析
• 区域分析
• 新兴技术
• 结论

第二章 市场概览

• 概述
• 宏观经济因素
• 波特五力分析

第三章 市场动态

• 市场动态
• 市场驱动因素
• 监理合规要求
• 复杂生技药品和先进治疗药物（ATMP）的兴起
• 生命科学领域的数位转型与工业4.0
• 市场限制因素
• 先进校准验证检验方案成本高昂
• 取得专业技术和监管知识的管道有限。
• 市场机会
• 数位化检验与无纸化品质体系
• 实施基于云端的 GxP（药品生产良好规范）系统和远端验证服务。

第四章 监管情势

• 概述
• 我们
• 欧洲
• 亚太地区

第五章：新兴科技与发展

• 重点
• 人工智慧驱动的检验和预测品质平台
• 数位检验生命週期管理系统
• 基于物联网的智慧校准和感测器监测
• 基于云端的合规平台和远端检验
• 用于检验和生物製程标准化的数位双胞胎

第六章 市场区隔分析

• 概述
• 细分市场
• 市场分析：按服务供应商
• 重点
• 内部
• 第三者
• OEM
• 市场分析：依服务类型
• 重点
• 电机与电子工程
• 机械工业
• 生命科学领域的机械测试应用
• 热相关
• 压力
• 移液器
• 流体流动/光学
• 其他的
• 市场分析：依产品类型
• 重点
• 装置
• 消耗品
• 市场分析：依最终用户划分
• 重点
• 製药和生物技术公司
• 研究实验室
• 製药合约研究组织
• 诊所和医院
• 按地区划分
• 市场分析：按地区划分
• 重点
• 北美洲
• 欧洲
• 亚太地区
• 其他地区

第七章 竞争讯息

• 重点
• 竞争分析
• 策略倡议
• M&A
• 合约、合作关係、伙伴关係

第八章附录

• 调查方法
• 资讯来源
• 简称
• 公司简介
• ADVANTEST CORP.
• BECKMAN COULTER INC.
• CROSS CO.
• DASSAULT SYSTEMES
• ENDRESS+HAUSER GROUP SERVICES AG
• HARVARD BIOSCIENCE INC.
• IBM CORP.
• INSIGHT CALIBRATION SERVICES INC.
• SGS Societe Generale de Surveillance SA
• TEKTRONIX INC.
• THERMO FISHER SCIENTIFIC INC.
• TRANSCAT INC.
• TRESCAL
• VAISALA
• VALGENESIS INC.

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

The North American market for validation, calibration, and standardization in life sciences was valued at $1.1 billion in 2025 and is estimated to reach $1.6 billion by 2030, at a CAGR of 6.8% from 2025 through 2030.

The Asia-Pacific market for validation, calibration, and standardization in life sciences was valued at $698.2 million in 2025 and is estimated to reach $997.2 million by 2030, at a CAGR of 7.4% from 2025 through 2030.

Report Scope

The report analyzes the trends in the global market for validation, calibration, and standardization in life sciences. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by service provider (in-house, third-party, original equipment manufacturer (OEM)), service type (electrotechnical, mechanical, thermal, pressure, pipette, fluid flow/optical, others), product type, and end user. Product type consists of instruments and consumables. Instruments are further segmented into biochemistry analyzers, pH meters, pressure and temperature calibrators, and conductivity meters. Consumables are segmented into calibration kits/sampling kits, glassware, filters, slides, and other items. End users consist of pharmaceutical and biotech companies, research laboratories, contract research organizations, and clinics and hospitals. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the Rest of Europe, China, Japan, India, South Korea, and the Rest of Asia-Pacific.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that cover financials, product portfolios, and recent developments.

Report Includes

• 52 data tables and 48 additional tables
• Overview and an analysis of the global markets for flexible printed circuit boards (FPCB) technology
• Analyses of global market trends, with market revenue data for 2024, estimates for 2025, forecast for 2027, and projected CAGRs through 2030
• Estimates of the size and revenue prospects for global flexible PCB market, along with a corresponding market share analysis by type, layer, application, end-use industry, and geographic region
• Facts and figures about the global market dynamics, technological advancements, emerging applications, innovations, prospects, regulations, and the impact of macroeconomic factors
• Insights derived from the Porter's Five Forces model, as well as global supply chain analyses
• Analysis of patents, emerging trends and new developments in the electronics manufacturing industry
• Analysis of the industry structure, including companies' market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG risk ratings scores and practices of leading companies
• Company profiles of major players within the industry, including Thermo Fisher Scientific, SGS SA, Trescal, ValGenesis Inc., and Transcat Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Analysis
• Emerging Technologies
• Conclusion

Chapter 2 Market Overview

• Overview
• Macroeconomic Factors
• Porter's Five Forces Analysis

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Regulatory Compliance Requirements
• Proliferation of Complex Biologics and Advanced Therapy Medicinal Products (ATMPs)
• Digital Transformation and Industry 4.0 in Life Sciences
• Market Restraints
• High Cost Associated with Advanced Calibration Verification Solutions
• Limited Availability of Specialized Technical and Regulatory Expertise
• Market Opportunities
• Digital Validation and Paperless Quality Systems
• Adoption of Cloud-Based Good X Practice (GxP) Systems and Remote Validation Services

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologies and Developments

• Key Takeaways
• AI-Driven Validation and Predictive Quality Platforms
• Digital Validation Lifecycle Management Systems
• IoT-Enabled Smart Calibration and Sensor-Based Monitoring
• Cloud-Based Compliance Platforms and Remote Validation
• Digital Twins for Validation and Bioprocess Standardization

Chapter 6 Market Segmentation Analysis

• Overview
• Segmentation Breakdown
• Market Analysis by Service Provider
• Key Takeaways
• In-House
• Third Party
• OEM
• Market Analysis by Service Type
• Key Takeaways
• Electrotechnical
• Mechanical
• Mechanical Testing Applications in Life Sciences
• Thermal
• Pressure
• Pipette
• Fluid Flow/Optical
• Others
• Market Analysis by Product Type
• Key Takeaways
• Instruments
• Consumables
• Market Analysis by End User
• Key Takeaways
• Pharmaceutical and Biotechnology Companies
• Research Laboratories
• Contract Research Organizations
• Clinics and Hospitals
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Analysis
• Strategic Initiatives
• Mergers and Acquisitions
• Agreements, Collaborations, and Partnerships

Chapter 8 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• ADVANTEST CORP.
• BECKMAN COULTER INC.
• CROSS CO.
• DASSAULT SYSTEMES
• ENDRESS+HAUSER GROUP SERVICES AG
• HARVARD BIOSCIENCE INC.
• IBM CORP.
• INSIGHT CALIBRATION SERVICES INC.
• SGS Societe Generale de Surveillance SA
• TEKTRONIX INC.
• THERMO FISHER SCIENTIFIC INC.
• TRANSCAT INC.
• TRESCAL
• VAISALA
• VALGENESIS INC.

List of Tables

• Summary Table : Global Market for Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 1 : Global Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
• Table 2 : Global Market for In-House Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 3 : Global Market for Third-Party Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 4 : Global Market for OEM Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 5 : Global Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
• Table 6 : Global Market for Electrotechnical Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 7 : Global Market for Mechanical Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 8 : Global Market for Thermal Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 9 : Global Market for Pressure Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 10 : Global Market for Pipette Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 11 : Global Market for Fluid Flow/Optical Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 12 : Global Market for Other Service Types of Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 13 : Global Market for Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
• Table 14 : Global Market for Instruments in Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 15 : Global Market for Instruments in Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
• Table 16 : Global Market for Consumables in Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 17 : Global Market for Consumables in Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
• Table 18 : Global Market for Validation, Calibration, and Standardization in Life Sciences, by End User, Through 2030
• Table 19 : Global Market for Validation, Calibration, and Standardization in Life Sciences for Pharmaceutical and Biotechnology Companies, by Region, Through 2030
• Table 20 : Global Market for Validation, Calibration, and Standardization in Life Sciences for Research Laboratories, by Region, Through 2030
• Table 21 : Global Market for Validation, Calibration, and Standardization in Life Sciences for Contract Research Organizations, by Region, Through 2030
• Table 22 : Global Market for Validation, Calibration, and Standardization in Life Sciences for Clinics and Hospitals, by Region, Through 2030
• Table 23 : Global Market for Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
• Table 24 : North American Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
• Table 25 : North American Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
• Table 26 : North American Market for Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
• Table 27 : North American Market for Validation, Calibration, and Standardization in Life Sciences, by End User, Through 2030
• Table 28 : North American Market for Validation, Calibration, and Standardization in Life Sciences, by Country, Through 2030
• Table 29 : European Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
• Table 30 : European Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
• Table 31 : European Market for Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
• Table 32 : European Market for Validation, Calibration, and Standardization in Life Sciences, by End User, Through 2030
• Table 33 : European Market for Validation, Calibration, and Standardization in Life Sciences, by Country, Through 2030
• Table 34 : Asia-Pacific Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
• Table 35 : Asia-Pacific Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
• Table 36 : Asia-Pacific Market for Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
• Table 37 : Asia-Pacific Market for Validation, Calibration, and Standardization in Life Sciences, by End User, Through 2030
• Table 38 : Asia-Pacific Market for Validation, Calibration, and Standardization in Life Sciences, by Country, Through 2030
• Table 39 : RoW Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
• Table 40 : RoW Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
• Table 41 : RoW Market for Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
• Table 42 : RoW Market for Validation, Calibration, and Standardization in Life Sciences, by End User, Through 2030
• Table 43 : Global Ranking of Companies in the Market for Validation, Calibration, and Standardization in Life Sciences, 2024
• Table 44 : M&A in the Market for Validation, Calibration, and Standardization in Life Sciences, 2024 and 2025
• Table 45 : Agreements and Partnerships in the Market for Validation, Calibration, and Standardization in Life Sciences, 2024-2025
• Table 46 : Information Sources Used for this Report
• Table 47 : Abbreviations Used in this Report
• Table 48 : Advantest Corp.: Company Snapshot
• Table 49 : Advantest Corp.: Financial Performance, FY 2023 and 2024
• Table 50 : Advantest Corp.: Product Portfolio
• Table 51 : Advantest Corp.: News/Key Developments, 2025
• Table 52 : Beckman Coulter Inc.: Company Snapshot
• Table 53 : Beckman Coulter Inc.: Product Portfolio
• Table 54 : CROSS Co.: Company Snapshot
• Table 55 : CROSS Co.: Product Portfolio
• Table 56 : CROSS Co.: News/Key Developments, 2025
• Table 57 : Dassault Systemes: Company Snapshot
• Table 58 : Dassault Systemes: Financial Performance, FY 2023 and 2024
• Table 59 : Dassault Systemes: Product Portfolio
• Table 60 : Dassault Systemes: News/Key Developments, 2025
• Table 61 : Endress+Hauser Group Services AG: Company Snapshot
• Table 62 : Endress+Hauser Group Services AG: Financial Performance, FY 2023 and 2024
• Table 63 : Endress+Hauser Group Services AG: Product Portfolio
• Table 64 : Endress+Hauser Group Services AG: News/Key Developments, 2024 and 2025
• Table 65 : Harvard Bioscience Inc.: Company Snapshot
• Table 66 : Harvard Bioscience Inc.: Financial Performance, FY 2023 and 2024
• Table 67 : Harvard Bioscience Inc.: Product Portfolio
• Table 68 : Harvard Bioscience Inc.: News/Key Developments, 2024 and 2025
• Table 69 : IBM Corp.: Company Snapshot
• Table 70 : IBM Corp.: Financial Performance, FY 2023 and 2024
• Table 71 : IBM Corp.: Product Portfolio
• Table 72 : IBM Corp.: News/Key Developments, 2024
• Table 73 : Insight Calibration Services Inc.: Company Snapshot
• Table 74 : Insight Calibration Services Inc.: Product Portfolio
• Table 75 : SGS Societe Generale de Surveillance SA: Company Snapshot
• Table 76 : SGS Societe Generale de Surveillance SA: Financial Performance, FY 2023 and 2024
• Table 77 : SGS Societe Generale de Surveillance SA: Product Portfolio
• Table 78 : SGS Societe Generale de Surveillance SA: News/Key Developments, 2024 and 2025
• Table 79 : Tektronix Inc.: Company Snapshot
• Table 80 : Tektronix Inc.: Product Portfolio
• Table 81 : Tektronix Inc.: News/Key Developments, 2023-2025
• Table 82 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 83 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
• Table 84 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 85 : Thermo Fisher Scientific Inc.: News/Key Developments, 2025
• Table 86 : Transcat Inc.: Company Snapshot
• Table 87 : Transcat Inc.: Financial Performance, FY 2023 and 2024
• Table 88 : Transcat Inc.: Product Portfolio
• Table 89 : Transcat Inc.: News/Key Developments, 2023-2025
• Table 90 : Trescal: Company Snapshot
• Table 91 : Trescal: Product Portfolio
• Table 92 : Trescal: News/Key Developments, 2024
• Table 93 : Vaisala: Company Snapshot
• Table 94 : Vaisala: Financial Performance, FY 2023 and 2024
• Table 95 : Vaisala: Product Portfolio
• Table 96 : Vaisala: News/Key Developments, 2024 and 2025
• Table 97 : ValGenesis Inc.: Company Snapshot
• Table 98 : ValGenesis Inc.: Product Portfolio
• Table 99 : ValGenesis Inc.: News/Key Developments, 2024 and 2025

List of Figures

• Summary Figure : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Region, 2024
• Figure 1 : Porter's Five Forces Analysis in the Global Market for Validation, Calibration, and Standardization in Life Sciences
• Figure 2 : Market Dynamics of Validation, Calibration, and Standardization in the Life Sciences Industry
• Figure 3 : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, 2024
• Figure 4 : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Service Type, 2024
• Figure 5 : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Product Type, 2024
• Figure 6 : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by End User, 2024
• Figure 7 : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Region, 2024
• Figure 8 : North American Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Country, 2024
• Figure 9 : European Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Country, 2024
• Figure 10 : Asia-Pacific Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Country, 2024
• Figure 11 : Advantest Corp.: Revenue Shares, by Country/Region, FY 2024
• Figure 12 : Dassault Systemes: Revenue Shares, by Country/Region, FY 2024
• Figure 13 : Endress+Hauser Group Services AG: Revenue Shares, by Country/Region, FY 2024
• Figure 14 : Harvard Bioscience Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 15 : IBM Corp.: Revenue Shares, by Business Unit, FY 2024
• Figure 16 : IBM Corp.: Revenue Shares, by Country/Region, FY 2024
• Figure 17 : SGS Societe Generale de Surveillance SA: Revenue Shares, by Business Unit, FY 2024
• Figure 18 : SGS Societe Generale de Surveillance SA: Revenue Shares, by Country/Region, FY 2024
• Figure 19 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 20 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 21 : Transcat Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 22 : Transcat Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 23 : Vaisala: Revenue Shares, by Business Unit, FY 2024
• Figure 24 : Vaisala: Revenue Shares, by Country/Region, FY 2024